A structural heart team at Mount Hospital in Perth have become the first doctors in the Asia-Pacific region to successfully perform a minimally invasive heart procedure using a new ground-breaking device.
The device, Abbott's TriClip, is for patients with severe tricuspid regurgitation (TR) who are at high risk of needing surgery.
TR is a condition in which the valve between the two right heart chambers does not close properly and results in abnormal leaking of blood. In severe cases, if left untreated, it can lead to an increased incidence of mortality, prolonged hospitalisation, and can negatively impact a patient's quality of life.
The technique performed allows for the repair of the valve with an implant through a vein in the leg without the need to open the patient's chest.
GenesisCare cardiologist Dr Wen-Loong Yeow said, "For the first time, hundreds of Australians with tricuspid regurgitation who are not eligible for open-heart surgery, sternotomy, cardiopulmonary bypass or cardioplegia, have a new treatment option that may improve symptoms and quality of life, without the potential risks of more traditional, invasive approaches."
"The procedure involved the implantation of a device to repair the regurgitation in the tricuspid valve. Post-procedure the patient is in good condition and recovering at home with excellent indicators for full recovery. He is an otherwise fit 90-year-old gentleman who is very much looking forward to being able to hop on his bike and get back into cycling," said Dr Yeow.
According to Dr Robert Larbalestier, Mount Hospital cardiothoracic surgeon, "Mount Hospital's expert cardiologists, cardiothoracic surgeons and imaging specialists are truly leading the way with this Asia-Pacific first procedure.
"Working with a focused heart team approach allows excellent patient outcomes for their recovery and these new technologies are broadening our options for patient care."
Mount Hospital general manager Reza Barzegari said the case was another example of the hospital team and its specialists being at the forefront of surgical innovation.
"We are delighted to be able to support our world-class surgeons in giving patients outstanding treatment and care. My congratulations to our structural heart team for this Asia-Pacific first, and we send our best wishes for our patient's speedy recovery," said Mr Barzegari.